(Q33865511)

English

Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).

scientific article

Statements

Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). (English)
Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit